Literature DB >> 8898690

Relationships between high oxygen extraction fraction in the acute stage and final infarction in reversible middle cerebral artery occlusion: an investigation in anesthetized baboons with positron emission tomography.

A R Young1, G Sette, O Touzani, P Rioux, J M Derlon, E T MacKenzie, J C Baron.   

Abstract

Studies in humans suggest that regions that show maximal increases in brain oxygen extraction fraction (OEF) in the hours following an ischemic episode are those most vulnerable for infarction and are often, although not always, associated with the final site of infarction. To clarify this issue, we followed the hemodynamic and metabolic characteristics of regions with an initially maximally increased OEF and compared them with the ultimately infarcted region in an experimental stroke model. Positron emission tomography (PET) was used to obtain functional images of the brain prior to and following reversible unilateral middle cerebral artery occlusion (MCAO) in 11 anesthetized baboons. To model early reperfusion, the clips were removed 6 h after occlusion. Successive measurements of regional CBF (rCBF), regional CMRO2 (rCMRO2), regional cerebral blood volume, and regional OEF (rOEF) were performed during the acute (up to 2 days) and chronic (> 15 days) stage. Late magnetic resonance imaging (MRI) scans (co-registered with PET) were obtained to identify infarction. Reversible MCAO produced an MRI-measurable infarction in 6 of 11 baboons; the others had no evidence of ischemic damage. Histological analysis confirmed the results of the MRI investigation but failed to show any evidence of cortical ischemic damage. The lesion was restricted to the head of the caudate nucleus, internal capsule, and putamen. The infarct volume obtained was 0.58 +/- 0.31 cm3. The infarcts were situated in the deep MCA territory, while the area of initially maximally increased OEF was within the cortical mantle. The mean absolute rCBF value in the infarct region of interest (ROI) was not significantly lower than in the highest-OEF ROI until 1-2 days post-MCAO. Cerebral metabolism in the deep MCA territory was always significantly lower than that of the cortical mantle; decreases in CMRO2 in the former region were evident as early as 1 h post-MCAO. In the cortical mantle, the rOEF was initially significantly higher than in the infarct-to-be zone. Subsequently, the OEF declined in both regions. The differences in the time course of changes in CMRO2 and OEF between these two regions, with the eventually infarcted area showing earlier metabolic degradation and in turn decline in OEF, presumably underlie their different final outcomes. In conclusion, following MCAO, the region that shows an early maximal increase in the OEF is both topographically and physiologically distinct from the region with final consolidated infarction if reperfusion is allowed at 6 h. This high OEF, although indicative of a threatened condition, is not an indicator of inescapable consolidated infarction and is thus a situation in which therapy could be envisaged. Whether or not it is at risk of infarction and thus constitutes one target for therapy remains to be seen.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8898690     DOI: 10.1097/00004647-199611000-00012

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  22 in total

1.  Use of spin echo T(2) BOLD in assessment of cerebral misery perfusion at 1.5 T.

Authors:  M Kavec; O H Gröhn; M I Kettunen; M J Silvennoinen; M Penttonen; R A Kauppinen
Journal:  MAGMA       Date:  2001-03       Impact factor: 2.310

2.  Mapping the dynamics of brain perfusion using functional ultrasound in a rat model of transient middle cerebral artery occlusion.

Authors:  Clément Brunner; Clothilde Isabel; Abraham Martin; Clara Dussaux; Anne Savoye; Julius Emmrich; Gabriel Montaldo; Jean-Louis Mas; Jean-Claude Baron; Alan Urban
Journal:  J Cereb Blood Flow Metab       Date:  2015-12-31       Impact factor: 6.200

3.  Defining the ischemic penumbra using magnetic resonance oxygen metabolic index.

Authors:  Hongyu An; Andria L Ford; Yasheng Chen; Hongtu Zhu; Rosana Ponisio; Gyanendra Kumar; Amirali Modir Shanechi; Naim Khoury; Katie D Vo; Jennifer Williams; Colin P Derdeyn; Michael N Diringer; Peter Panagos; William J Powers; Jin-Moo Lee; Weili Lin
Journal:  Stroke       Date:  2015-02-26       Impact factor: 7.914

4.  Elevated brain oxygen extraction fraction measured by MRI susceptibility relates to perfusion status in acute ischemic stroke.

Authors:  Audrey P Fan; Ahmed A Khalil; Jochen B Fiebach; Greg Zaharchuk; Arno Villringer; Kersten Villringer; Claudine J Gauthier
Journal:  J Cereb Blood Flow Metab       Date:  2019-02-07       Impact factor: 6.200

Review 5.  Thrombolytic therapy for stroke: a review with particular reference to elderly patients.

Authors:  K W Muir; M Roberts
Journal:  Drugs Aging       Date:  2000-01       Impact factor: 3.923

6.  Oxygen metabolism MRI - A comparison with perfusion imaging in a rat model of MCA branch occlusion and reperfusion.

Authors:  Philip V Little; Sandra E Kraft; Arvin Chireh; Peter Damberg; Staffan Holmin
Journal:  J Cereb Blood Flow Metab       Date:  2019-12-16       Impact factor: 6.200

7.  PET in Cerebrovascular Disease.

Authors:  William J Powers; Allyson R Zazulia
Journal:  PET Clin       Date:  2010-01-01

8.  Oxygen metabolism in ischemic stroke using magnetic resonance imaging.

Authors:  Hongyu An; Qingwei Liu; Yasheng Chen; Katie D Vo; Andria L Ford; Jin-Moo Lee; Weili Lin
Journal:  Transl Stroke Res       Date:  2011-12-13       Impact factor: 6.829

9.  Near-infrared measurements of brain oxygenation in stroke.

Authors:  François Moreau; Runze Yang; Vivek Nambiar; Andrew M Demchuk; Jeff F Dunn
Journal:  Neurophotonics       Date:  2016-02-11       Impact factor: 3.593

10.  Evaluation of MR-derived cerebral oxygen metabolic index in experimental hyperoxic hypercapnia, hypoxia, and ischemia.

Authors:  Hongyu An; Qingwei Liu; Yasheng Chen; Weili Lin
Journal:  Stroke       Date:  2009-04-09       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.